| Citation: |
WANG Kaiqiong, XING Yilei, QIAO Xin, LI Sizong, GONG Dongwei, YU Zhiwei, WU Yiqiang. Effects of miR-144 on Proliferation, Migration, Invasion and PI3K Pathway of Pancreatic Cancer SW1990 Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(10): 879-883. DOI: 10.3971/j.issn.1000-8578.2019.18.1524
|
To investigate the effects of microRNA-144 (miR-144) on the proliferation, migration, invasion and phosphoinositide-3 kinase (PI3K) pathway of pancreatic cancer SW1990 cells.
The expression of miR-144 in human normal pancreatic epithelial cell line HPDE and pancreatic cancer cells SW1990 were detected by RT-qPCR. SW1990 cells were transfected with miR-144 negative control plasmid (negative transfection group) and miR-144 mimic plasmid (miR-144 overexpression group), and untreated cells were taken as blank control group. The expression level of miR-144 in each group was detected by RT-qPCR. CCK-8 assay was used to detect cell proliferation. Plate clone formation assay was used to detect colony formation. Transwell assay was used to detect cell migration and invasion. The expression levels of PI3K and phosphorylated protein (p-PI3K), serine-threonine protein kinase (Akt) and phosphorylated protein (p-Akt) proteins in PI3K pathway were detected by Western blot.
The expression level of miR-144 in SW1990 cells was significantly lower than that in HPDE cells (P < 0.05). The expression level of miR-144 in miR-144 overexpression group was significantly higher than those in blank control group and negative transfection group (P < 0.05). Cells proliferation rate, colony formation, the number of migration and invasion cells and the expression levels of p-PI3K and p-Akt proteins in the overexpression group were significantly lower than those in the blank control group and negative transfection group (all P < 0.05).
miR-144 is lowly expressed in pancreatic cancer cells SW1990. The up-regulation of miR-144 expression could effectively inhibit the proliferation, migration and invasion of pancreatic cancer cells, which may be related to the inhibition of PI3K pathway.
| [1] |
张亚娜, 马望, 王峰, 等.二甲双胍对胰腺癌和胰腺癌干细胞中ALDH1表达的作用[J].肿瘤防治研究, 2017, 44(3): 177-183. doi: 10.3971/j.issn.1000-8578.2017.03.005
Zhang YN, Ma W, Wang F, et al. Effects of metformin on ALDH1 expression in pancreatic cancer and pancreatic cancer stem cells[J]. Zhong Liu Fang Zhi Yan Jiu, 2017, 44(3): 177-183. doi: 10.3971/j.issn.1000-8578.2017.03.005
|
| [2] |
邓小斌, 孙圣荣. MicroRNA-221在恶性肿瘤中的研究进展[J].武汉大学学报(医学版), 2016, 37(6): 925-928. http://www.cnki.com.cn/Article/CJFDTotal-FCYC201601012.htm
Deng XB, Sun SR. Research progress of miRNA-221 in malignant tumors[J]. Wuhan Da Xue Xue Bao(Yi Xue Ban), 2016, 37(6): 925-928. http://www.cnki.com.cn/Article/CJFDTotal-FCYC201601012.htm
|
| [3] |
Yin Y, Cai J, Meng F, et al. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55[J]. Cancer Biol Ther, 2018, 19(4): 306-315. doi: 10.1080/15384047.2017.1416934
|
| [4] |
张涓娟, 蒲宇, 李勇, 等. PI3K/AKT和MAPK/ERK1/2信号通路对胰腺癌PANC-1细胞VEGF表达的影响[J].川北医学院学报, 2014, 29(1): 44-48. doi: 10.3969/j.issn.1005-3697.2014.01.09
Zhang JJ, Pu Y, Li Y, et al. Influence of PI3K and MAPKs signaling pathways on expression of VEGF in human pancreatic cancer PANC-1 cells[J]. Chuanbei Yi Xue Yuan Xue Bao, 2014, 29(1): 44-48. doi: 10.3969/j.issn.1005-3697.2014.01.09
|
| [5] |
Bisht S, Feldmann G. Novel targets in pancreatic cancer therapy-current status and ongoing translational efforts[J]. Oncol Res Treat, 2018, 41(10): 596-602. doi: 10.1159/000493437
|
| [6] |
周显飞, 田舍, 王杰, 等. microRNA-29c对人胰腺癌细胞侵袭转移的抑制作用及机制[J].贵阳医学院学报, 2016, 41(9): 997-1001. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gyyxyxb201609002
Zhou XF, Tian S, Wang J, et al. Study on microRNA-29c inhibition effect and mechanism on human pancreatic cancer cells migration[J]. Guiyang Yi Xue Yuan Xue Bao, 2016, 41(9): 997-1001. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gyyxyxb201609002
|
| [7] |
Zhao Y, Zhao L, Ischenko I, et al. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer[J]. Target Oncol, 2015, 10(4): 535-548. doi: 10.1007/s11523-015-0360-2
|
| [8] |
Zhu G, Zhou L, Liu H, et al. MicroRNA-224 Promotes Pancreatic Cancer Cell Proliferation and Migration by Targeting the TXNIP-Mediated HIF1α Pathway[J]. Cell Physiol Biochem, 2018, 48(4): 1735-1746. doi: 10.1159/000492309
|
| [9] |
Qin A, Qian W. MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression[J]. Int J Mol Med, 2018, 42(5): 2503-2514. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=58b628d3f96585a67da5add6694903d3
|
| [10] |
Chen S, Lip L, Li J, et al. MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR[J]. Cell Physiol Biochem, 2015, 35(3): 997-1007. doi: 10.1159/000369755
|
| [11] |
李伟, 王兆松, 董秋萍, 等.肺鳞癌中miR-144靶基因预测及其生物信息学分析[J].天津医科大学学报, 2018, 24(4): 287-290. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=tianjykdxxb201804004
Li W, Wang ZS, Dong QP, et al. Bioinformatic analysis and prediction of miR-144 target genes in lung squamous cell carcinoma[J]. Tianjin Yi Ke Da Xue Xue Bao, 2018, 24(4): 287-290. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=tianjykdxxb201804004
|
| [12] |
Ren K, Liu QQ, An ZF, et al. MiR-144 functions as tumor suppressor by targeting PIM1 in gastric cancer[J]. Eur Rev Med Pharmacol Sci, 2017, 21(13): 3028-3037. http://europepmc.org/abstract/MED/28742204
|
| [13] |
Han B, Feng D, Yu X, et al. MicroRNA-144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C-X-C motif chemokine ligand 11[J]. Exp Ther Med, 2018, 16(3): 1935-1943. https://www.spandidos-publications.com/etm/16/3/1935/abstract
|
| [14] |
Han S, Zhu J, Zhang Y. miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1[J]. Med Sci Monit Basic Res, 2018, 24: 40-46. doi: 10.12659/MSMBR.907333
|
| [15] |
Yao Q, Gu A, Wang Z, et al. MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2[J]. Exp Ther Med, 2018, 15(3): 3088-3095. doi: 10.3892/etm.2018.5763
|
| [16] |
Wang S, Yan Y, Cheng Z, et al. Sotetsuflavone suppresses invasion and metastasis in non-small-cell lung cancer A549 cells by reversing EMT via the TNF-α/NF-κB and PI3K/AKT signaling pathway[J]. Cell Death Discov, 2018, 4: 26.
|
| [17] |
Feng Y, Zu LL, Zhang L. MicroRNA-26b inhibits the tumor growth of human liver cancer through the PI3K/Akt and NF-κB/MMP-9/VEGF pathways[J]. Oncol Rep, 2018, 39(5): 2288-2296.
|
| [18] |
张洋, 刘晓菲, 王楠, 等.阳和化岩汤联合曲妥珠对HER-2高表达型乳腺癌细胞PTEN-PI3K/Akt通路及VEGFC的影响研究[J].江苏中医药, 2018, 50(6): 79-82. doi: 10.3969/j.issn.1672-397X.2018.06.031
Zhang Y, Liu XF, Wang N, et al. Effects of Yanghe Huayan Decoction combined with trastuzum on PTEN-PI3K/Akt pathway and VEGFC in HER-2 high expression breast cancer cells[J]. Jiangsu Zhong Yi Yao, 2018, 50(6): 79-82. doi: 10.3969/j.issn.1672-397X.2018.06.031
|
| [19] |
Chen HX, Xu XX, Tan BZ, et al. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma[J]. Cell Physiol Biochem, 2017, 41(3): 933-946. doi: 10.1159/000460510
|
| [20] |
Tao P, Wen H, Yang B, et al. miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC[J]. Exp Ther Med, 2018, 15(1): 562-568.
|
| [1] | WANG Ya'nan, LU Wenping, MEI Heting, CUI Yongjia, ZHUO Zhili. Risk of Recurrence or Metastasis of Breast Cancer by LNG-IUS: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2022, 49(8): 786-791. DOI: 10.3971/j.issn.1000-8578.2022.21.1536 |
| [2] | XIA Lin, YU Guozheng, TANG Jing. Diagnostic Value of Circular RNAs for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 864-870. DOI: 10.3971/j.issn.1000-8578.2021.21.0069 |
| [3] | LIANG Tong, LIU Huajie, DA Mingxu. Metabolic Syndrome and Risk of Gastric Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 268-273. DOI: 10.3971/j.issn.1000-8578.2021.20.0957 |
| [4] | SHAO Lihua, ZHANG Qiuning, LUO Hongtao, YANG Zhen, LIU Ruifeng, TIAN Jinhui, LI Zheng, WANG Xiaohu, YANG Kehu. Carbonions and Proton Therapy for Hepatocellular Carcinoma: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2020, 47(5): 358-366. DOI: 10.3971/j.issn.1000-8578.2020.19.1158 |
| [5] | JIAN Yaowen, WANG Lei, Liu Ye, HE Mingyan, RANG Weiqing. A Meta-analysis of Dietary Vitamin Consumption and Risk of Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(2): 108-111. DOI: 10.3971/j.issn.1000-8578.2020.19.0007 |
| [6] | KUANG Yuhui, CHEN Xinju, XU Fangbiao. Meta-analysis of Efficacy and Safety of Jinlong Capsule Combined with Chemoradiotherapy on Liver Metastases[J]. Cancer Research on Prevention and Treatment, 2020, 47(1): 63-69. DOI: 10.3971/j.issn.1000-8578.2020.19.0619 |
| [7] | CAO Lingzhi, XIE Jianping, PENG Xiaodong, WEN Huling, LI Suping, YANG Yaowu. Association of Iodine Intake and Iodine-enriched Food with Risk of Thyroid Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2016, 43(7): 616-622. DOI: 10.3971/j.issn.1000-8578.2016.07.015 |
| [8] | LIU Min, SONG Yang, YANG Fuguo. Effect of Food Intake on Risk of Rectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1343-1347. DOI: 10.3971/j.issn.1000-8578.2014.12.020 |
| [9] | Ma Jun, Nie Shengnan, Shi Benling, Zuo Wenshu. Meta Analysis on Relationship between Soyfood and Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 218-221. DOI: 10.3971/j.issn.1000-8578.2012.02.025 |
| [10] | QIU Yue-feng, CAI Lin. Meta-analysis on Relationship between Body Mass Index and Lung Cancer Risk[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 218-222. DOI: 10.3971/j.issn.1000-8578.2010.02.025 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: